Bioxyne Limited (BXN) is an Australian life science, health and medical technology company involved in the development, manufacture and distribution of nutritional supplements and beauty products through wholesale and direct sales channels. The Group has a global distribution agreement with Denmark’s Chr Hansen to manufacture, market, supply and distribute its proprietary probiotic strain of Lactobacillus Fermentum PCC for over the counter dietary supplement products.
Bioxyne Limited belongs to Consumer Staple sector and under industry of Personal Products. You can get more information about this company via their website: http://www.bioxyne.com.
This a small cap company with market cap of 7 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.
Dividend Growth Chart
The following chart shows you how bxn dividend grows in the recent years.